क्यूआर कोड

Assessment of clinical immunogenicity of inotuzumab ozogamicin in patients with non-Hodgkin lymphoma and acute lymphoblastic leukemia

Abstract Introduction Inotuzumab ozogamicin (InO) is an antibody-drug conjugate composed of a recombinant, humanized immunoglobulin type G, subtype 4 (IgG4) antibody covalently bound to a semisynthetic derivative of calicheamicin via an acid-labile linker. It was developed for the treatment of relap...

पूर्ण विवरण

में बचाया:
मुख्य लेखकों: Darshana Jani, John Nowak, Ying Chen, Joseph Boni, Boris Gorovits
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: SpringerOpen 2018-02-01
श्रृंखला:AAPS Open
विषय:
Anti-drug antibody
Immunogenicity
Neutralizing antibody
Inotuzumab ozogamicin (InO)
Pharmacokinetics
Calicheamicin
ऑनलाइन पहुंच:http://link.springer.com/article/10.1186/s41120-018-0021-5
टैग: टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन